Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 22095262)

1.

Antimalarial efficacy of a quantified extract of Nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 1: a clinical phase IIA trial.

Mesia K, Tona L, Mampunza MM, Ntamabyaliro N, Muanda T, Muyembe T, Cimanga K, Totté J, Mets T, Pieters L, Vlietinck AJ.

Planta Med. 2012 Feb;78(3):211-8. doi: 10.1055/s-0031-1280359. Epub 2011 Nov 17.

PMID:
22095262
2.

Anthocephaline, a new indole alkaloid and cadambine, a potent inhibitor of DNA topoisomerase IB of Leishmania donovani (LdTOP1LS), isolated from Anthocephalus cadamba.

Kumar A, Chowdhury SR, Jatte KK, Chakrabarti T, Majumder HK, Jha T, Mukhopadhyay S.

Nat Prod Commun. 2015 Feb;10(2):297-9.

PMID:
25920266
3.

Using the whole plant to treat malaria.

Harrington M.

Lab Anim (NY). 2015 Mar;44(3):78. doi: 10.1038/laban.721. No abstract available.

PMID:
25693095
4.

Anuvasan Basti in escalating dose is an alternative for Snehapana before Vamana and Virechana: Trends from a pilot study.

Kadus PA, Vedpathak SM.

J Ayurveda Integr Med. 2014 Oct-Dec;5(4):246-50. doi: 10.4103/0975-9476.147445.

5.

Thiamin supplementation does not reduce the frequency of adverse events after anti-malarial therapy among patients with falciparum malaria in southern Laos.

Mayxay M, Khanthavong M, Cox L, Sichanthongthip O, Imwong M, Pongvongsa T, Hongvanthong B, Phompida S, Vanisaveth V, White NJ, Newton PN.

Malar J. 2014 Jul 15;13:275. doi: 10.1186/1475-2875-13-275.

6.

Treatment of mild and moderate type-2 diabetes: open prospective trial with Hintonia latiflora extract.

Korecova M, Hladikova M.

Eur J Med Res. 2014 Mar 28;19:16. doi: 10.1186/2047-783X-19-16.

7.

Antimalarial efficacy, cytotoxicity, and genotoxicity of methanolic stem bark extract from Hintonia latiflora in a Plasmodium yoelii yoelii lethal murine malaria model.

Rivera N, López PY, Rojas M, Fortoul TI, Reynada DY, Reyes AJ, Rivera E, Beltrán HI, Malagón F.

Parasitol Res. 2014 Apr;113(4):1529-36. doi: 10.1007/s00436-014-3797-9. Epub 2014 Feb 19.

PMID:
24549754
8.

Clinical trials with … drugs? Based on 2 projects in Alzheimer's disease and malaria.

Dal-Ré R, Carné X.

Rev Clin Esp (Barc). 2013 Jun-Jul;213(5):251-5. doi: 10.1016/j.rce.2013.02.011. Epub 2013 May 3. English, Spanish.

PMID:
23648125
9.

[Study on tolerability for safflower peony ointment in clinical trial phase I].

Lu LG, Wu SQ, Liang D.

Zhongguo Zhong Yao Za Zhi. 2013 Jan;38(1):123-6. Chinese.

PMID:
23596888
10.

[Improvement of symptoms in mild hyperthyroidism with an extract of Lycopus europaeus (Thyreogutt® mono)].

Eiling R, Wieland V, Niestroj M.

Wien Med Wochenschr. 2013 Feb;163(3-4):95-101. doi: 10.1007/s10354-012-0167-z. Epub 2012 Dec 18. German.

PMID:
23247973
11.

A phase I dose-escalation study to evaluate tolerability in a Western population to T89, a modern cardiovascular herbal medicine.

Ling S, Luo RZ, Nheu L, Guo ZX, Sun H, Komesaroff PA.

J Cardiovasc Pharmacol. 2012 Dec;60(6):513-9. doi: 10.1097/FJC.0b013e31826f6179.

PMID:
23232790
12.

Oral administration of French maritime pine bark extract (Flavangenol(®)) improves clinical symptoms in photoaged facial skin.

Furumura M, Sato N, Kusaba N, Takagaki K, Nakayama J.

Clin Interv Aging. 2012;7:275-86. doi: 10.2147/CIA.S33165. Epub 2012 Jul 27.

13.

Antimalarial efficacy of a quantified extract of Nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 2: a clinical phase IIB trial.

Mesia K, Tona L, Mampunza MM, Ntamabyaliro N, Muanda T, Muyembe T, Musuamba T, Mets T, Cimanga K, Totté J, Pieters L, Vlietinck AJ.

Planta Med. 2012 Jun;78(9):853-60. doi: 10.1055/s-0031-1298488. Epub 2012 Apr 26.

PMID:
22538476
14.
15.

Using quality of life measures in a Phase I clinical trial of noni in patients with advanced cancer to select a Phase II dose.

Issell BF, Gotay CC, Pagano I, Franke AA.

J Diet Suppl. 2009;6(4):347-59. doi: 10.3109/19390210903280272.

16.

Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.

Supan C, Mombo-Ngoma G, Dal-Bianco MP, Ospina Salazar CL, Issifou S, Mazuir F, Filali-Ansary A, Biot C, Ter-Minassian D, Ramharter M, Kremsner PG, Lell B.

Antimicrob Agents Chemother. 2012 Jun;56(6):3165-73. doi: 10.1128/AAC.05359-11. Epub 2012 Mar 19.

17.

Therapeutic effects and safety of Rhodiola rosea extract WS® 1375 in subjects with life-stress symptoms--results of an open-label study.

Edwards D, Heufelder A, Zimmermann A.

Phytother Res. 2012 Aug;26(8):1220-5. doi: 10.1002/ptr.3712. Epub 2012 Jan 6.

PMID:
22228617
18.

A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs.

McCarthy JS, Sekuloski S, Griffin PM, Elliott S, Douglas N, Peatey C, Rockett R, O'Rourke P, Marquart L, Hermsen C, Duparc S, Möhrle J, Trenholme KR, Humberstone AJ.

PLoS One. 2011;6(8):e21914. doi: 10.1371/journal.pone.0021914. Epub 2011 Aug 22.

19.

Potential of a Khaya ivorensis -Alstonia boonei extract combination as antimalarial prophylactic remedy.

Tepongning RN, Lucantoni L, Nasuti CC, Dori GU, Yerbanga SR, Lupidi G, Marini C, Rossi G, Esposito F, Habluetzel A.

J Ethnopharmacol. 2011 Sep 1;137(1):743-51. doi: 10.1016/j.jep.2011.06.036. Epub 2011 Jun 30.

PMID:
21742022
20.

A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.

Chilengi R, Juma R, Abdallah AM, Bashraheil M, Lodenyo H, Nyakundi P, Anabwani E, Salim A, Mwambingu G, Wenwa E, Jemutai J, Kipkeu C, Oyoo GO, Muchohi SN, Kokwaro G, Niehues T, Lang T, Nzila A.

Malar J. 2011 Mar 16;10:63. doi: 10.1186/1475-2875-10-63.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk